Gupta R K, Lallu S
Department of Laboratory Services, Wellington Hospital, New Zealand.
Diagn Cytopathol. 1997 Mar;16(3):238-41. doi: 10.1002/(sici)1097-0339(199703)16:3<238::aid-dc9>3.0.co;2-b.
Malignant melanomas are known to present diverse patterns and this can result in considerable difficulties for an interpretation of malignancy type from cytohistologic material. Such difficulties are further compounded, if melanin pigment cannot be demonstrated by conventional histochemical stains; unfortunately many cases do exhibit this feature, especially in its metastases. This study was designed to review cases of amelanotic metastatic malignant melanomas in a variety of cytologic samples which were received from 40 patients with a known history of malignant melanoma. Cytomorphologically, the cases were classified as classical, carcinoma-like, spindle cell type, lymphoma-like, and undifferentiated type (Table I). While in 36 of the cases, the diagnosis of metastases from a melanoma was confirmed based on an immunopositivity to a variety of melanoma markers (Table III), in four of the cases, the immunostaining indicated metastases from another primary source, which was subsequently found. Based on our study, we are of the opinion that an immunologic characterization is useful to conclusively diagnose the majority of cases of metastatic amelanotic malignant melanomas. Furthermore, we feel that a reliance on a single melanoma marker is not justified, and a panel of antibodies should be used to distinguish a metastatic amelanotic malignant melanoma from other metastatic neoplasms.
恶性黑色素瘤呈现出多种模式,这可能给从细胞组织学材料判断恶性肿瘤类型带来相当大的困难。如果黑色素不能通过传统组织化学染色显示,这些困难会进一步加剧;不幸的是,许多病例确实表现出这一特征,尤其是在转移灶中。本研究旨在回顾40例已知有恶性黑色素瘤病史患者的各种细胞学样本中的无色素性转移性恶性黑色素瘤病例。在细胞形态学上,这些病例被分为经典型、癌样型、梭形细胞型、淋巴瘤样型和未分化型(表I)。在36例病例中,基于对多种黑色素瘤标志物的免疫阳性反应确诊为黑色素瘤转移(表III),而在4例病例中,免疫染色显示为其他原发灶转移,随后得以发现。基于我们的研究,我们认为免疫特征对于最终诊断大多数无色素性转移性恶性黑色素瘤病例是有用的。此外,我们认为仅依赖单一黑色素瘤标志物是不合理的,应该使用一组抗体来区分无色素性转移性恶性黑色素瘤与其他转移性肿瘤。